Literature DB >> 24527719

National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients.

K V Juul1, M Schroeder, S Rittig, J P Nørgaard.   

Abstract

CONTEXT: Epidemiological data for central diabetes insipidus (CDI) are sparse.
OBJECTIVE: The purpose of this study was to provide accurate epidemiological data on CDI on a national level. DESIGN AND
SETTING: This was a drug utilization and patient registry study during a 5-year period from 2007 to 2011.
METHODS: We used the Danish National Prescription Registry data linked with the Danish National Patient Registry to study the epidemiology of CDI using waiting time distribution and other pharmacoepidemiological methods. PATIENTS: A total of 1285 patients with CDI were recorded in the observation period and given 9309 prescriptions for desmopressin in the nasal formulation, orodispersible tablet, or conventional tablet.
RESULTS: The period prevalence rate of CDI in Denmark over the 5-year period investigated was 23 CDI patients per 100 000 inhabitants, with a higher prevalence in children and older adults (>80 years of age). The 1-year period prevalence rate of CDI decreased in Denmark over the 5 years from approximately 10 to 7 CDI patients per 100 000 inhabitants. The yearly incidence rate of new cases of CDI was found to be 3 to 4 patients per 100 000. The incidence of (presumable) congenital CDI was found to be 2 infants per 100 000 infants. Half of the patients with CDI prescribed as oral treatment were provided dosing instructions to only administer the drug before bedtime, and one third of the CDI patients either had no specific instructions or were instructed to use the drug as needed. Hospital admissions due to severe hyponatremia occurred in 0.9% of patients over a 5-year period, predominantly in females with an incidence ratio of women to men of 1.8:1.
CONCLUSION: Half of the cases of CDI are acquired later in life. At least half of the patients with CDI are instructed to prevent nocturnal polyuria, but it is not clear whether their CDI remains uncontrolled during the daytime or, alternatively, whether they use desmopressin only as needed. Female patients with CDI had approximately twice the number of hospital admissions due to severe hyponatremia than male patients with CDI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24527719     DOI: 10.1210/jc.2013-4411

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Neuroimaging of central diabetes insipidus-when, how and findings.

Authors:  N C Adams; T P Farrell; A O'Shea; A O'Hare; J Thornton; S Power; P Brennan; S Looby
Journal:  Neuroradiology       Date:  2018-08-10       Impact factor: 2.804

Review 2.  Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.

Authors:  Xinyi Chin; Shao Wei Teo; Soo Ting Lim; Yong Hong Ng; How Chuan Han; Fabian Yap
Journal:  Eur J Clin Pharmacol       Date:  2022-02-23       Impact factor: 2.953

Review 3.  Diagnosis and Management of Central Diabetes Insipidus in Adults.

Authors:  Maria Tomkins; Sarah Lawless; Julie Martin-Grace; Mark Sherlock; Chris J Thompson
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

4.  Etiological and clinical characteristics of central diabetes insipidus in children: a single center experience.

Authors:  Janel D Hunter; Ali S Calikoglu
Journal:  Int J Pediatr Endocrinol       Date:  2016-02-11

5.  Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center.

Authors:  Zenei Arihara; Kanako Sakurai; Satsuki Niitsuma; Ryota Sato; Shozo Yamada; Naoko Inoshita; Naoko Iwata; Haruki Fujisawa; Takashi Watanabe; Atsushi Suzuki; Kazuhiro Takahashi; Yoshihisa Sugimura
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.996

6.  Desmopressin-Induced Severe Hyponatremia with Central Pontine Myelinolysis: A Case Report.

Authors:  Tanzib Hossain; Marya Ghazipura; Vineet Reddy; Pedro J Rivera; Vikramjit Mukherjee
Journal:  Drug Saf Case Rep       Date:  2018-04-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.